trending Market Intelligence /marketintelligence/en/news-insights/trending/nuzkmmc1lmdouci0g3-jya2 content esgSubNav
In This List

Five Prime Therapeutics names chief scientific officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Five Prime Therapeutics names chief scientific officer

Five Prime Therapeutics Inc. appointed Bryan Irving as executive vice president and chief scientific officer.

Irving joined the South San Francisco, Calif.-based clinical-stage biotechnology company in August 2017 as vice president of research.